June 2023 FDA Recall Albuterol Sulfate by Cipla Usa, Inc.
D-0938-2023 - Defective container

This Class I drug recall was voluntarily initiated by Cipla Usa, Inc. on June 27, 2023 for the product Albuterol Sulfate. The FDA reported the reason for recall as defective container. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0938-2023

Reason for Recall
Defective container: empty inhaler and leakage observed through the inhaler valve due to partially missing bottom seat (gasket).
Initiated
06-27-2023
Reported
07-19-2023
Quantity
278,538 canisters

Recall Profile & Regulatory Data

Class I - is a situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death.
Nationwide in the US
Albuterol Sulfate Inhalation Aerosol, 90 mcg, 200 Metered Inhalation, net content 6.7 g canister packaged in a box, Rx only, Manufactured by: Cipla Ltd, Indore SE Z, Pithampur, India, Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ, 07059, NDC 69097-142-60

Batch or Lot Expiration Information

Lot# IB20045, IB20055, IB20056, IB20057, IB20059, IB20072, Exp Nov. 30, 2023

Affected Packages Involved in this Recall